| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 42399-49-5 | (2S-cis)-(+)-2,3-二氫-3-羥基-2-(4-甲氧苯基)-1,5-苯并硫氮雜卓-4(5H)-酮 | (2S-cis)-(+)-2,3-Dihydro-3-hydroxy-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one; 1,5-Benzothiazepin-4(5H)-one,2,3-dihydro-3-hydroxy-2-(4-methoxyphenyl)-, (2S-cis)-; (2S,3S)-3-Hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one |  | C16H15NO3S | 詳情 | 供應商 |
| 150323-38-9 | [1(1S,2R),5(S)]-2,3,5-三脫氧-N-(2,3-二氫-2-羥基-1H-茚-1-基)-5-[2-[(叔丁基氨基)甲酰]-1-哌嗪基]-2-(苯? | [1(1S,2R),5(S)]-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-[2-[[(1,1-dimethylethyl; D-erythro-Pentonamide,2,3,5-trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-[2-[[(1,1-dimethylethyl)amino]carbonyl]-1-piperazinyl]-2-(phenylmethyl)-,[1(1S,2R),5(S)]- |  | C30H42N4O4 | 詳情 | 供應商 |
| 176760-98-8 | (S)-10-氰甲基-9-氟-2,3-二氫-3-甲基-7-氧代-7H-吡啶并[1,2,3-de]-1,4-苯并惡嗪-6-羧酸 | (S)-10-(Cyanomethyl)-9-fluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-c; 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylicacid, 10-(cyanomethyl)-9-fluoro-2,3-dihydro-3-methyl-7-oxo-, (S)- |  | C15H11FN2O4 | 詳情 | 供應商 |
| 71552-60-8 | α-[2,3-二氫-3-(四氫-2,4,6-三氧-5(2H)-嘧啶亞基)-1H-異吲哚-1-亞基]-1,4-二氫-4-氧-2-喹唑啉乙腈 | alpha -[2,3-dihydro-3-(tetrahydro-2,4,6-trioxo-5(2H)-pyrimidinylidene)-1H-isoindol-1-ylidene]-1,4-d2; 2-Quinazolineacetonitrile,a-[2,3-dihydro-3-(tetrahydro-2,4,6-trioxo-5(2H)-pyrimidinylidene)-1H-isoindol-1-ylidene]-1,4-dihydro-4-oxo-(9CI); C.I. 56295; C.I. Pigment Red 260; Paliogen Red L 3585HD; Pigment Red 260 |  | C22H12N6O4 | 詳情 | 供應商 |
| 302911-95-1 | (3R-順)-(?)-2,3-二氫-7a-甲基-3-苯基吡咯并[2,1-b]惡唑-5(7aH)-酮 | Pyrrolo[2,1-b]oxazol-5(7aH)-one,2,3-dihydro-7a-methyl-3-phenyl-; 2,3-Dihydro-7a-methyl-3-phenylpyrrolo[2,1-b]oxazol-5(7aH)-one |  | C13H13NO2 | 詳情 | 供應商 |
| 302911-94-0 | (3R-順)-(?)-2,3-二氫-3-異丙基-7a-甲基吡咯并[2,1-b]惡唑-5(7aH)-酮 | Pyrrolo[2,1-b]oxazol-5(7aH)-one,2,3-dihydro-7a-methyl-3-(1-methylethyl)-; 2,3-Dihydro-7a-methyl-3-isopropylpyrrolo[2,1,-b]oxazol-5(7aH)-one |  | C10H15NO2 | 詳情 | 供應商 |
| 143140-06-1 | (3S-順)-2,3-二氫-7a-甲基-3-苯基吡咯-[2,1-b]噁唑-5(7aH)-酮 | Pyrrolo[2,1-b]oxazol-5(7aH)-one,2,3-dihydro-7a-methyl-3-phenyl-, (3S,7aR)-; Pyrrolo[2,1-b]oxazol-5(7aH)-one,2,3-dihydro-7a-methyl-3-phenyl-, (3S-cis)- |  | C13H13NO2 | 詳情 | 供應商 |
| 147726-43-0 | (Z)-2,3-二氫-2-[甲氧基(甲巰基)亞甲基]-1-茚酮 | 1H-Inden-1-one,2,3-dihydro-2-[methoxy(methylthio)methylene]-, (Z)- (9CI); (Z)-2,3-dihydro-2-[methoxy(methylthio)methylene]-1H-Inden-1-one |  | C12H12O2S | 詳情 | 供應商 |
| 295325-62-1 | (S)-α-氨基-2,3-二氫-4-甲氧基-7-硝基-D-基-1H-吲哚-1-戊酸 | 1H-Indole-1-pentanoicacid, a-amino-2,3-dihydro-4-methoxy-7-nitro-d-oxo-, (aS)-; MNI-CAGED-L-GLUTAMATE; (S)-ALPHA-AMINO-2,3-DIHYDRO-4-METHOXY-7-NITRO-D-OXO-1H-INDOLE-1-PENTANOIC ACID |  | C14H17N3O6 | 詳情 | 供應商 |
| 18877-34-4 | (S)-(+)-2,3-二氫-1H-吡咯并[2,1-c][1,4]苯并二氮卓-5,11(10H,11aH)-二酮 | 1H-Pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H,11aH)-dione,2,3-dihydro-, (11aS)-; 1H-Pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H,11aH)-dione,2,3-dihydro-, (S)-; 5H-Pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H)-dione,1,2,3,11a-tetrahydro-, L- (8CI) |  | C12H12N2O2 | 詳情 | 供應商 |
| 26494-55-3 | (3-氧代-2,3-二氫-4H-1,4-苯并惡嗪)-4-乙酸 | 4H-1,4-Benzoxazine-4-aceticacid, 2,3-dihydro-3-oxo- |  | C10H9NO4 | 詳情 | 供應商 |
| 61589-14-8 | (2,3-二氫-1H-吲哚-1-基)苯基甲酮 | 1-BENZYL-2,3-DIHYDRO-1H-INDOLE |  | C15H15N | 詳情 | 供應商 |
| 66635-93-6 | (1R)-5-苯基-2,3-二氫-1H-吡啶-1-羧酸 | (R)-(+)-Ketorolac; (1R)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid; (R)-(+)-Ketorolac; (R)-Ketorolac |  | C15H13NO3 | 詳情 | 供應商 |
| 96392-15-3 | (R)-N-(2,3-二氫-1H-茚基)腺苷 | PD 117519; (R)-N-(2,3-Dihydro-1H-indenyl)adenosine; CI 947; N-[(1R)-2,3-Dihydro-1H-inden-1-yl]adenosine; PD 117519; N-[(1R)-Indan-1-yl]adenosine; N-[[(R)-2,3-Dihydro-1H-inden]-1α-yl]adenosine |  | C19H21N5O4 | 詳情 | 供應商 |
| 294662-18-3 | (S)-(-)-9-氟-2,3-二氫-3-甲基-10-(4-甲基-1-哌嗪基)-7-氧-7H-吡啶駢[1,2,3-DE]-[1,4]苯駢惡嗪-6-羧酸乳酸? | LEVOFLOXACIN LACTATE |  | C21H26FN3O7 | 詳情 | 供應商 |
| 5718-26-3 | ; 2-[(1,5-二氫-3-甲基-5-氧代-1苯基-4H-吡唑-4-亞基)乙亞基]2,3-二氫-1,3,3-三甲基-1H吲哚-5-甲酸甲酯 | methyl 2-[(1,5-dihydro-3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-ylidene)ethylidene]-1,3,3-trimethylindol; methyl 2-[(1,5-dihydro-3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-ylidene)ethylidene]-1,3,3-trimethylindoline-5-carboxylate; 1H-Indole-5-carboxylic acid, 2-(1,5-dihydro-3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-ylidene)ethylidene-2,3-dihydro-1,3,3-trimethyl-, methyl ester; 2-[(1,5-dihydro-3-methyl-5-oxo-1-phenyl-4h-pyrazol-4-ylidene)ethylidene]-2,3-dihydro-1,3,3-trimethyl-1h-indole-5-carboxylic aci methyl ester; Methyl 2-[(1,5-Dihydro-3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-ylidene)-ethylidene]-1,3,3-trimethylindoline-5-carboxylate; Bayer Macrolex Orange R; 2-[2-(1,5-Dihydro-3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-ylidene)ethylidene]-2,3-dihydro-1,3,3-trimethyl-1H-indole-5-carboxylic acid methyl ester |  | C25H25N3O3 | 詳情 | 供應商 |
| 1142953-55-6 | (R)-2-(溴甲基)-2,3-二氫苯并[B][1,4]二惡烷; (R)-2-(溴甲基)-2,3-二氫苯并[B][1,4]二惡烷 | (R)-2-(bromomethyl)-2,3-dihydrobenzo[b][1,4]dioxine |  | C9H9BrO2 | 詳情 | 供應商 |
| 709031-38-9 | (S)-N-BOC-2,3-二氫吡咯-2-甲酰胺; (S)-N-BOC-2,3-二氫吡咯-2-甲酰胺 | 1H-Pyrrole-1-carboxylic acid, 2-(aMinocarbonyl)-2,3-dihydro-, 1,1-diMethylethyl ester, (2S)-; 1H-Pyrrole-1-carboxylic acid, 2-(aMinocarbonyl)-2,3-dihydro-, 1,1-diMethylethyl ester, (2S)-; (S)-Boc-2-carbaMoyl-2,3-dihydro-1H-pyrrole | 無 | 詳情 | 供應商 | |
| 334949-59-6 | (3Z)-3-[[[3-[(二甲基氨基)甲基]苯基]氨基]苯亞甲基]-2,3-二氫-2-氧代-1H-吲哚-6-甲酰胺; (3Z)-3-[[[3-[(二甲基氨基)甲基]苯基]氨基]苯亞甲基]-2,3-二氫-2-氧代-1H-吲哚-6-甲酰胺 | (3Z)-3-[[[3-[(Dimethylamino)methyl]phenyl]amino]phenylmethylene]-2,3-dihydro-2-oxo-1H-indole-6-carboxamide |  | C25H24N4O2 | 詳情 | 供應商 |
| 656247-18-6 | (3Z)-2,3-二氫-3-[[[4-[甲基[2-(4-甲基-1-哌嗪基)乙酰]氨基]苯基]氨基]苯亞甲基]-2-氧代-1H-吲哚-6-甲酸甲酯乙磺酸鹽 | 3Z)-2,3-Dihydro-3-[[[4-[methyl[2-(4-methyl-1-piperazinyl)acetyl]amino]phenyl]amino]phenylmethylene]- | 無 | C31H33N5O4.C2H6O3S | 詳情 | 供應商 |